drugset / Trial / NCT03255226
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload
NaSingle-groupOpen-labelTreatment
Summary
To determine the efficacy, safety, and dose and regimen of tolvaptan in pediatric CHF patients with volume overload
Timeline
- Start
- 2018-03-07
- Primary completion
- 2021-07-11
- Completion
- 2021-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tolvaptan | Small molecule | 1 % | — |
| Subject | Tolvaptan | Small molecule | 15 mg | — |